Immucor sells investment in instrument manufacturer:
This article was originally published in Clinica
Executive Summary
Blood analysis equipment maker Immucor has sold its stake in Lionheart Technologies for about $1.3m. It was bought by Lionheart, the owner of Bio-Tek Instruments, one of Immucor's development and manufacturing partners. Winooski, Vermont-based Bio-Tek manufactures Immucor's ABS2000 automated blood bank laboratory analyser, and is developing a third-generation automated assay instrument for small to medium-sized hospitals. Bio-Tek's vice-president of business development, Adam Alpert, said the company "anticipate[d] no changes in this relationship as a consequence of the stock sale".
You may also be interested in...
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.